'Ms patients' diaporamas de présentation

MULTIPLE SCLEROSIS AND NEUROPSYCHOLOGICAL FUNCTIONING: MANAGING COGNITIVE DEFICITS

MULTIPLE SCLEROSIS AND NEUROPSYCHOLOGICAL FUNCTIONING: MANAGING COGNITIVE DEFICITS. Dr. Lesley Ritchie, C.Psych. Ms. Jodie Gawryluk, B.A. Department of Clinical Health Psychology University of Manitoba. Introduction to the brain Understanding MS The treatment team What is neuropsychology?

1.46k views • 102 slides

The Use of Vitamin D in Clinical Practice

The Use of Vitamin D in Clinical Practice. John J Cannell, MD Executive Director, Vitamin D Council. The Use of Vitamin D in Clinical Practice. Disclosures I am paid a salary as the Executive Director of the Vitamin D Council, a 501(c)(3) non-profit.

938 views • 77 slides

Multiple Sclerosis: Overview for Dentists

641 views • 38 slides

Looking Into the Crystal Ball

Looking Into the Crystal Ball. Promising Research in Multiple Sclerosis Treatment. What do we need to study in MS?. Why do people get MS? Why do people get different types of MS? Why does the course of MS vary so much? What actual cells are abnormal in MS?

536 views • 38 slides

LDN Prescribing And Research In Scotland

450 views • 38 slides

477 views • 37 slides

474 views • 34 slides

Effect of Cognitive Fatigue on Language of MS Patients

473 views • 31 slides

Presentation made to the ACCT Conference 2008 Daniel Hubert Michelle Gauthier November 24, 2008

528 views • 28 slides

Declaration of Conflict of Interest or Relationship

ISMRM 2011 E-Poster #4643. mcDESPOT-Derived MWF Improves EDSS Prediction in MS Patients Compared to Atrophy Measures Alone. J. Su 1 , H.H.Kitzler 2 , M. Zeineh 1 , S.C .Deoni 3 , C.Harper-Little 2 , A.Leung 2 , M.Kremenchutzky 2 , and B.K .Rutt 1

421 views • 27 slides

Brief Cognitive Assessment based on Consensus Standards in the US and Abroad

Brief Cognitive Assessment based on Consensus Standards in the US and Abroad. Dawn Langdon PhD. MS care providers needs. Most interested in receiving consultation on cognition (31.0%) Most interested in CME relating to cognition (40.1%) Highest preference for live conference.

412 views • 21 slides

Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis

HALT-MS Phase II Clinical Trial of H igh Dose Immunosuppressive Therapy and A uto L ogous Hematopoietic Stem Cell T ransplantation for Active Relapsing-Remitting MS George J. Hutton, MD. Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis.

491 views • 21 slides

Counselling requirements for MS- patients in the state of Brandenburg

232 views • 16 slides

American Academy of ozonoterapy

American Academy of ozonoterapy. Annual Meeting 2014 Dallas March 26-29 2014. OZONE THERAPY AND MULTIPLE SCLEROSIS: WHY?.

313 views • 13 slides

Managing Symptoms of Multiple Sclerosis by Exercising

Exercise often helps to ease difficulties associated with multiple sclerosis. However, it is important to take the necessary precautions if you really want your exercise routine to give you good result. One of the most important things to know is that Multiple Sclerosis (MS) patients should never overdo.

264 views • 11 slides

Multiple Sclerosis

213 views • 11 slides

WINTER

01. WINTER. MS LAB. Template. MS LAB SYSTEM. About us. 02.

254 views • 11 slides

Scientific Discoveries in Israel

326 views • 9 slides

Severe Depression and MS: A Dangerous Co-Morbidity that Often Goes Untreated

Severe Depression and MS: A Dangerous Co-Morbidity that Often Goes Untreated. A Research Project by Kelly Black East Tennessee State University August 2005. As many as 50% of patients with Multiple Sclerosis suffer from depression ranging from mild to severe.

201 views • 8 slides

RESULTS Relapses (two-year primary end point) (Figure 1)

100 views • 1 slides